Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.05.19
中国建银投资证券有限责任公司关于公司使用部分逾额召募资金的保荐意见
2010.05.19
内幕信息及知情人挂号和报备制度(2010年5月)
2010.05.19
关于使用部分逾额召募资金送还银行贷款和增补永世性流动资金的通告
2010.05.19
重大信息内部报告制度(2010年5月)
2010.05.19
第一届董事会第十八次聚会决议通告
2010.05.19
关于签署《召募资金三方羁系协议》的通告
2010.05.15
澄清通告
2010.05.13
股票生意异常波动通告
2010.05.05
2010年第一季度财务资料
2010.05.05
首次果真刊行股票上市通告书
第一页
上一页
146
147
148
149
150
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】